The fetal diagnosis of galactosialidosis is performed by measuring car
boxypeptidase (cathepsin A) activity in cultured villous cells and by
immunofluorescence analysis with an antibody against an oligopeptide c
orresponding to the N-terminal domain of the human mature protective p
rotein. Neither carboxypeptidase activity nor immunofluorescence was d
etected in cultured villous cells derived from an at-risk fetus or in
cultured fibroblasts derived from the sister with galactosialidosis. N
euraminidase and beta-galactosidase activities were also confirmed to
be deficient or low. A direct assay system for protective protein/cath
epsin A is useful for the accurate prenatal diagnosis of galactosialid
osis. (C) 1997 Elsevier Science B.V.